SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients ...

CeriBell (NASDAQ:CBLL – Get Free Report) shares fell 3.3% during trading on Friday .The company traded as low as $24.66 and last traded at $25.00. 24,940 shares changed hands during trading, a ...

TD Cowen analyst Joshua Jennings raised the firm’s price target on Ceribell (CBLL) to $36 from $31 and keeps a Buy rating on the shares. The firm said its target increase reflects a slightly ...

TD Cowen：维持CeriBell(CBLL.US)评级，由买入调整至买入评级, 目标价由31.00美元调整至36.00美元。 Ceribell（CBLL.US）公司简介：CeriBell Inc 是一家商业阶段的 ...

Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. Its products include ...

SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients ...

SUNNYVALE, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with ...